Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

Background. Retinopathy of prematurity (ROP) is one of the common complications of prematurity. Intravitreal injection of ranibizumab (IVR), an antivascular endothelial growth factor (VEGF) drug, showed significant benefit for ROP. However, there are concerns about systemic complications of anti-VEG...

Full description

Bibliographic Details
Main Authors:	Xuting Chen, Lin Zhou, Qi Zhang, Yu Xu, Peiquan Zhao, Hongping Xia
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2019/2985161

Similar Items

Intravitreal ranibizumab injections in patients with retinopathy of prematurity (ROP)
by: Zuluaga Gómez, Liliana María, et al.
Published: (2018-01-01)

The vascularization process after intravitreal ranibizumab injections for aggressive posterior retinopathy of prematurity
by: Emine Alyamaç Sukgen, et al.

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
by: Yu Xu, et al.
Published: (2016-01-01)

Fluorescein angiography of retinal vascular involution after intravitreal injection of ranibizumab for retinopathy of prematurity
by: Yong Cheng, et al.
Published: (2019-01-01)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
by: Xiu-Juan Li, et al.
Published: (2016-01-01)

Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment
by: Qiujing Huang, et al.
Published: (2017-01-01)

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
by: Osman Melih Ceylan, et al.

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity
by: Muhammet Kazim Erol, et al.
Published: (2015-12-01)

Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity
by: Mostafa M El Manhaly, et al.
Published: (2020-01-01)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
by: Ágata Mota, et al.
Published: (2012-04-01)

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis®)
by: Horowitz SA, et al.
Published: (2020-02-01)

Effect of Ranibizumab intravitreal injection as an adjunct before vitrectomy surgery in the treatment of patients with proliferative diabetic retinopathy
by: Yang Zhang, et al.
Published: (2015-08-01)

Clinical effect of intravitreal injection of Ranibizumab for severe proliferative diabetic retinopathy
by: Yun-Cheng Ma, et al.
Published: (2016-01-01)

Efficacy of intravitreal injection of Aflibercept vs Ranibizumab in the treatment of diabetic retinopathy
by: Chang Huang, et al.
Published: (2021-05-01)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
by: Anand Vinekar
Published: (2021-01-01)

Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity
by: Parijat Chandra, et al.
Published: (2019-01-01)

Inhibition of retinopathy of prematurity in rat by intravitreal injection of sorafenib
by: Li-Li Tian, et al.
Published: (2014-04-01)

Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
by: Jun Xu, et al.
Published: (2020-04-01)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
by: Elcin Suren, et al.
Published: (2020-01-01)

Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2019-01-01)

Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity
by: Anil Babanrao Gangwe, et al.
Published: (2021-01-01)

Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity
by: Arámbulo O, et al.
Published: (2015-10-01)

Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab
by: Qizhe Tong, et al.
Published: (2018-06-01)

The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China
by: Qing-Yu Meng, et al.
Published: (2019-07-01)

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
by: Masahiro Onda, et al.
Published: (2019-01-01)

Evaluation of intravitreal ranibizumab injection as a line of treatment for chronic central serous retinopathy
by: Emad A.A Saliem
Published: (2019-01-01)

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01)

Clinical effect of laser photocoagulation combined with minimal doses of intravitreal Ranibizumab for aggressive posterior retinopathy of prematurity
by: He Cao, et al.
Published: (2019-11-01)

Intravitreal ranibizumab as salvage therapy in an extremely low-birth-weight infant with rush type retinopathy of prematurity
by: Chun-Ju Lin, et al.
Published: (2012-01-01)

Fluorescein Angiographic Findings of Peripheral Retinal Vasculature after Intravitreal Conbercept versus Ranibizumab for Retinopathy of Prematurity
by: Enzhong Jin, et al.
Published: (2019-01-01)

Clinical effect of vitrectomy with intravitreal ranibizumab for diabetic retinopathy
by: Yun-Peng Wang, et al.
Published: (2014-07-01)

Erratum: Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
by: .
Published: (2019-01-01)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
by: Tsuyoshi Minami, et al.
Published: (2014-10-01)

Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
by: Yewande Olubunmi Babalola, et al.
Published: (2020-01-01)

Intravitreal injection of ranibizumab (Lucentis) versus pan-retinal photocoagulation as a preoperative adjuvant before vitrectomy in management of proliferative diabetic retinopathy
by: Mohammed S Ahmed
Published: (2021-01-01)

Intravitreal injection with Ranibizumab combined with extra panrentinal photocoagulation for proliferative diabetic retinopathy with disc neovascularization
by: Le Yang, et al.
Published: (2018-09-01)

Vascular endothelial growth factor inhibitors for retinopathy of prematurity
by: O.V. Zhukova, et al.
Published: (2020-11-01)

Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity
by: Swapnil M Parchand, et al.
Published: (2021-01-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study
by: Jiao Lyu, et al.
Published: (2019-02-01)